Clinical Trial Update: ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for envafolimab, administered alone or with ipilimumab, in patients with undifferentiated pleomorphic sarcoma or myxofib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myxofibrosarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Envafolimab (envafolimab)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Tracon Pharmaceuticals Inc. | Conditions: Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING